Ascension Via Christi's Structural Heart team is participating in two pivotal U.S. clinical trials. These trials will help advance new therapeutic options for patients with failing tricuspid valves. Until recently, patients with failing tricuspid valves have had limited treatment options. This results in heart failure, frequent hospitalizations and a diminished quality of life.